DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
André F, O'Regan R, Ozguroglu M, Toi M, Xu B, Jerusalem G. et al
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): A randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol 2014;
15: 580-91
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.